Discordant HER2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
Research output: Contribution to journal › Article
Targeted therapy with trastuzumab has proven to be effective for patients with gastric cancer overexpressing the human epidermal growth factor receptor 2 (HER2). Further studies are needed to determine the best method for assessment of HER2 overexpression. Moreover, the prognostic value of HER2 overexpression, including the significance of tumour heterogeneity, remains unclear.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Early online date||2015 May 27|
|Publication status||Published - 2015|
Related research output
CHARLOTTA HEDNER, 2016, Lund: Lund University, Faculty of Medicine. 78 p.
Research output: Thesis › Doctoral Thesis (compilation)